Abstract
A series of new acrylamide derivatives containing 1,2,3-thiadiazole were synthesized, characterized, and evaluated for their anti-hepatitis B virus (HBV) activities in vitro. The IC50 of compounds 9b (10.4 microg/mL), 9c (3.59 microg/mL) and 17a (9.00 microg/mL) of the inhibition on the replication of HBV DNA were higher than that of the positive control lamivudine (14.8 microg/mL). Compound 9d exhibited significant activity against secretion of HBeAg (IC50=12.26 microg/mL).
Copyright (c) 2010 Elsevier Masson SAS. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acrylamide / chemical synthesis
-
Acrylamide / chemistry
-
Acrylamide / pharmacology*
-
Antiviral Agents / chemical synthesis*
-
Antiviral Agents / chemistry
-
Antiviral Agents / pharmacology*
-
Cell Line
-
Cell Survival / drug effects
-
Crystallography, X-Ray
-
Hepatitis B virus / drug effects*
-
Hepatitis B virus / physiology*
-
Humans
-
Microbial Sensitivity Tests
-
Models, Molecular
-
Molecular Structure
-
Stereoisomerism
-
Thiadiazoles / chemistry*
-
Virus Replication / drug effects*
Substances
-
Antiviral Agents
-
Thiadiazoles
-
Acrylamide